BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 28888850)

  • 1. Ultrasound-based follow-up does not increase survival in early-stage melanoma patients: A comparative cohort study.
    Ribero S; Podlipnik S; Osella-Abate S; Sportoletti-Baduel E; Manubens E; Barreiro A; Caliendo V; Chavez-Bourgeois M; Carrera C; Cassoni P; Malvehy J; Fierro MT; Puig S
    Eur J Cancer; 2017 Nov; 85():59-66. PubMed ID: 28888850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of time to sentinel-node biopsy on the prognosis of cutaneous melanoma.
    Tejera-Vaquerizo A; Nagore E; Puig S; Robert C; Saiag P; Martín-Cuevas P; Gallego E; Herrera-Acosta E; Aguilera J; Malvehy J; Carrera C; Cavalcanti A; Rull R; Vilalta-Solsona A; Lannoy E; Boutros C; Benannoune N; Tomasic G; Aegerte P; Vidal-Sicart S; Palou J; Alos LL; Requena C; Traves V; Pla Á; Bolumar I; Soriano V; Guillén C; Herrera-Ceballos E
    Eur J Cancer; 2015 Sep; 51(13):1780-93. PubMed ID: 26072362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.
    Burmeister BH; Henderson MA; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
    Lancet Oncol; 2012 Jun; 13(6):589-97. PubMed ID: 22575589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regression does not predict nodal metastasis or survival in patients with cutaneous melanoma.
    Burton AL; Gilbert J; Farmer RW; Stromberg AJ; Hagendoorn L; Ross MI; Martin RC; McMasters KM; Scoggins CR; Callender GG
    Am Surg; 2011 Aug; 77(8):1009-13. PubMed ID: 21944515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pigmentation in the sentinel node correlates with increased sentinel node tumor burden in melanoma patients.
    van Lanschot CG; Koljenović S; Grunhagen DJ; Verhoef C; van Akkooi AC
    Melanoma Res; 2014 Jun; 24(3):261-6. PubMed ID: 24608184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative measurement of melanoma spread in sentinel lymph nodes and survival.
    Ulmer A; Dietz K; Hodak I; Polzer B; Scheitler S; Yildiz M; Czyz Z; Lehnert P; Fehm T; Hafner C; Schanz S; Röcken M; Garbe C; Breuninger H; Fierlbeck G; Klein CA
    PLoS Med; 2014 Feb; 11(2):e1001604. PubMed ID: 24558354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound morphology criteria predict metastatic disease of the sentinel nodes in patients with melanoma.
    Voit C; Van Akkooi AC; Schäfer-Hesterberg G; Schoengen A; Kowalczyk K; Roewert JC; Sterry W; Eggermont AM
    J Clin Oncol; 2010 Feb; 28(5):847-52. PubMed ID: 20065175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node ultrasound during melanoma follow-up significantly improves metastasis detection compared with clinical examination alone: a study on 433 patients.
    Krüger U; Kretschmer L; Thoms KM; Padeken M; Peter Bertsch H; Schön MP; Zutt M
    Melanoma Res; 2011 Oct; 21(5):457-63. PubMed ID: 21730878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of time interval between primary melanoma excision and sentinel node biopsy on positivity rate and survival.
    Oude Ophuis CM; van Akkooi AC; Rutkowski P; Voit CA; Stepniak J; Erler NS; Eggermont AM; Wouters MW; Grünhagen DJ; Verhoef CK
    Eur J Cancer; 2016 Nov; 67():164-173. PubMed ID: 27669503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultrasonographic detection of regional lymph node metastases in patients with intermediate or thick malignant melanoma.
    Brountzos EN; Panagiotou IE; Bafaloukos DI; Kelekis DA
    Oncol Rep; 2003; 10(2):505-10. PubMed ID: 12579298
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective cohort study of ultrasound surveillance of regional lymph nodes in patients with intermediate-risk cutaneous melanoma.
    Hayes AJ; Moskovic E; O'Meara K; Smith HG; Pope RJE; Larkin J; Thomas JM
    Br J Surg; 2019 May; 106(6):729-734. PubMed ID: 30816996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dermal melanoma: A report on prognosis, outcomes, and the utility of sentinel lymph node biopsy.
    Doepker MP; Thompson ZJ; Harb JN; Messina JL; Puleo CA; Egan KM; Sarnaik AA; Gonzalez RJ; Sondak VK; Zager JS
    J Surg Oncol; 2016 Jan; 113(1):98-102. PubMed ID: 26661407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sentinel and nonsentinel node status in stage IB and II melanoma patients: two-step prognostic indicators of survival.
    Cascinelli N; Bombardieri E; Bufalino R; Camerini T; Carbone A; Clemente C; Lenisa L; Mascheroni L; Maurichi A; Pennacchioli E; Patuzzo R; Santinami M; Tragni G
    J Clin Oncol; 2006 Sep; 24(27):4464-71. PubMed ID: 16983115
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long term follow up of the EORTC 18952 trial of adjuvant therapy in resected stage IIB-III cutaneous melanoma patients comparing intermediate doses of interferon-alpha-2b (IFN) with observation: Ulceration of primary is key determinant for IFN-sensitivity.
    Eggermont AM; Suciu S; Rutkowski P; Kruit WH; Punt CJ; Dummer R; Salès F; Keilholz U; de Schaetzen G; Testori A;
    Eur J Cancer; 2016 Mar; 55():111-21. PubMed ID: 26790144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted high-resolution ultrasound is not an effective substitute for sentinel lymph node biopsy in patients with primary cutaneous melanoma.
    Sanki A; Uren RF; Moncrieff M; Tran KL; Scolyer RA; Lin HY; Thompson JF
    J Clin Oncol; 2009 Nov; 27(33):5614-9. PubMed ID: 19786669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patterns of initial recurrence and prognosis after sentinel lymph node biopsy and selective lymphadenectomy for melanoma.
    Wagner JD; Ranieri J; Evdokimow DZ; Logan T; Chuang TY; Johnson CS; Jung SH; Wenck S; Coleman JJ
    Plast Reconstr Surg; 2003 Aug; 112(2):486-97. PubMed ID: 12900606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sonographic criteria for diagnosing sentinel node metastases in melanoma patients].
    Ulrich J; van Akkooi AC; Eggermont AM; Voit CA
    Ultraschall Med; 2015 Apr; 36(2):149-53. PubMed ID: 24764213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors predictive of pelvic lymph node involvement and outcomes in melanoma patients with metastatic sentinel lymph node of the groin: A multicentre study.
    Mozzillo N; Pasquali S; Santinami M; Testori A; Di Marzo M; Crispo A; Patuzzo R; Verrecchia F; Botti G; Montella M; Rossi CR; Caracò C
    Eur J Surg Oncol; 2015 Jul; 41(7):823-9. PubMed ID: 25800935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of ultrasound of sentinel nodes in the pre- and post-operative evaluation of stage I melanoma patients.
    Testori A; Lazzaro G; Baldini F; Tosti G; Mosconi M; Lovati E; Bossi C; Sanvito S; Stanganelli I; Mazzarol G; De Salvo GL; Trifirò G; Biffi R; Bellomi M
    Melanoma Res; 2005 Jun; 15(3):191-8. PubMed ID: 15917701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasonography using simple diagnostic criteria vs palpation for the detection of regional lymph node metastases of melanoma.
    Saiag P; Bernard M; Beauchet A; Bafounta ML; Bourgault-Villada I; Chagnon S
    Arch Dermatol; 2005 Feb; 141(2):183-9. PubMed ID: 15724014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.